Skip to content

NeoGenomics NEO Net margin

Net margin at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
6.7%+1.1pp
Quest Diagnostics logo
Quest DiagnosticsDGX
9.1%+0.2pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-148.1%+154pp
Guardant Health logo
Guardant HealthGH
-40.1%-8.1pp
Natera, Inc. logo
Natera, Inc.NTRA
-14.6%+0.6pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-22.2%-9.5pp

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

Based on trailing twelve months.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's net margin?
NeoGenomics (NEO) reported net margin of -13.3% in Q1 2026.
How has NeoGenomics's net margin changed year-over-year?
NeoGenomics's net margin decreased by 15.2% year-over-year, from -11.5% to -13.3%.
What is the long-term trend for NeoGenomics's net margin?
Over 5 years (2020 to 2025), NeoGenomics's net margin has grown at a 73.7% compound annual growth rate (CAGR), from 0.9% to -14.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.